FIL Capital Management / Fidelity Asia Ventures
Fidelity Asia invests $15m in Chinese orthopedic hospital operator
Fidelity Growth Partners Asia has invested RMB90 million ($15 million) in Zhejiang Banger Medical Management, a Chinese orthopedic hospital operator.
China Asset Management backs $332m iSoftStone take-private
Chinese IT services provider iSoftStone Holdings has received a take-private proposal from its CEO and chairman, who is working in conjunction with ChinaAMC Capital Management, an alternative investment platform affiliated to fund management company China...
Fidelity, Qualcomm lead Series C round for Bigshoebazaar
Fidelity Growth Partners and Qualcomm Ventures have led a Series C round of funding worth INR1 billion (US$18 million) for Indian online wholesaler Bigshoebazaar. Existing investors Nexus Venture Partners and Catamaran Ventures also participated.
India to launch $360m pharma fund
The Indian government is contemplating launching an INR20 billion ($367 million) venture capital fund to invest in research and development (R&D) in the pharmaceutical sector.
MineralTree in $6.3m round led by Fidelity India
Fidelity Growth Partners India has led a $6.3 financing round for Boston-based MineralTree, which provides cloud-based secure payments services for small- and medium-sized enterprises (SMEs). Existing investor .406 Ventures also participated.
India's Voicetap to raise capital from venture capital
Voicetap, a technology startup focused on mobile-education, has received $1 million from private investors. It is also in talks with other venture capital funds in the US, Singapore and India to raise $7 million over the next few months.
Fidelity to launch its biggest China VC fund
Fidelity Investments is planning to launch its biggest Chinese venture capital fund next year, worth at least $250 million.
High India pharma valuations price PE firms out of the market
With strategic investors drawn to India’s rapidly growing pharma sector, private equity players must either go niche or get out
FGPI gives $41m cash boost to Aptuit Laurus
Fidelity Growth Partners India (FGPI), the India-focused the private equity arm of Fidelity Worldwide Investment, has invested INR2 billion ($40.6 million) in pharma company Aptuit Laurus.
Sequoia, Baring in talks to sell Coastal Projects
India’s Coastal Projects, which is backed by Sequoia Capital and Baring Private Equity Asia among others, is reportedly in talks with German firm Hochtief about a possible sale of the business.
Fidelity Growth Partners makes India education investment
Fidelity Growth Partners will take an undisclosed minority stake in Mind Shaper Technologies for about $15 million, according to statement from the Delhi-based education company. Mind Shaper operates under the Classteacher Learning Systems brand, which...
SciClone buys VC-backed NovaMed
California-based SciClone Pharmaceuticals Inc. has acquired Fidelity Asia Ventures- and Atlas Venture-backed NovaMed Pharmaceuticals Inc., a Chinese specialty pharmaceutical firm, for approximately $62 million in the form of cash and shares.
VC-backed NetQin to IPO
PE-backed Chinese mobile technology firm NetQin mobile has submitted its filings to the New York Stock Exchange.
VC investee ISoftStone files for NYSE IPO
Venture capital-backed iSoftStone Holdings Ltd., a Beijing-based provider of IT consulting and software services, has filed for a $50 million IPO on NYSE.
The changing face of venture
With the US back on the radar as the market of choice for the best and brightest in TMT, where do Asian companies fit into the picture, and how are VC funds finding them early enough to make a profit?
Nexus, Nokia, Fidelity, Cisco invest India's Netmagic
Nokia Growth Partners and Cisco Systems have led existing investors Nexus Venture Partners and Fidelity International into an INR70 crore ($15.7 million) investment round for Netmagic Solutions, an IT hosting services provider.
WuXi Pharma sees no exit via Charles River
VC-invested PRC pharmaceutical major WuXi PharmaTech saw its $1.6 billion sale to US peer Charles River Laboratories fail over opposition from major shareholders in Massachusetts-based Charles River, including Neuberger Berman and hedge fund Jana Partners.
WuXi Pharma exit to Charles River nixed
VC-invested PRC pharmaceutical major WuXi PharmaTech has seen its $1.6 billion sale to US peer Charles River Laboratories fail over opposition from major shareholders in Massachusetts-based Charles River, including Neuberger Berman and hedge fund Jana...
Ceyuan, Fidelity, GSR, Sequoia back NetQin
Ceyuan Ventures, Fidelity Asia, GSR Ventures and Sequoia Capital China have all participated in a $20 million third funding round for NetQin Mobile Inc., a Beijing-headquartered mobile comms security service provider.
Industry Q&A: Norman Chen, Partner, Fidelity Asia Ventures
Chen talks to AVCJ’s Paul Mackintosh about opportunities for healthcare investments in China
Healthcare: The next China VC horizon?
PRC healthcare VCs take the market’s temperature
Fidelity Asia invests PRC medical device distributor
Fidelity Asia Ventures, the Asian venture and growth capital arm of Fidelity International Ltd and its US affiliate Fidelity Biosciences, has jointly invested $10 million in TCT Medical, which claims to be the largest medical device distributor and service...
PRC BPO play iSoftStone attracts VCs
Everbright Private Equity, a subsidiary of listed Chinese red-chip financial conglomerate China Everbright Ltd., and other venture capital firms, including AsiaVest Partners, Fidelity Asia Ventures, Infotech Pacific Ventures, Mitsui Ventures Global Fund,...